With reference to its earlier letter dated 12-Jun-24 on the inspection conducted by USFDA for its Manufacturing facility at Indrad, Gujarat from 03-Jun-24 to 12-Jun-24. In furtherance to the aforementioned intimation, Torrent Pharmaceuticals has informed that the USFDA has issued Establishment Inspection Report (‘EIR’) with Voluntary Action Indicated (‘VAI’) classification for the said manufacturing facility and the inspection has now been successfully closed by the USFDA.
The above information is a part of company’s filings submitted to BSE.
